ARR-17477

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameARR-17477
Drug Alias NameARL-17477
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase inhibitors
TargetsNitric oxide synthase
Therapy Area/IndicationsPainAmyotrophic Lateral SclerosisStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstra Arcus USA IncAstrazeneca R&D Charnwood
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstra Arcus USA IncAstrazeneca R&D Charnwood
Active IndicationsN/A
Inactive IndicationsPainAmyotrophic Lateral SclerosisStroke

Other Information

ATC CodeN/A
Related LinksN/A